Search results for "Vascularization"

showing 10 items of 519 documents

Intravascular pillars and pruning in the extraembryonic vessels of chick embryos.

2010

To investigate the local mechanical forces associated with intravascular pillars and vessel pruning, we studied the conducting vessels in the extraembryonic circulation of the chick embryo. During the development days 13-17, intravascular pillars and blood flow parameters were identified using fluorescent vascular tracers and digital time-series video reconstructions. The geometry of selected vessels was confirmed by corrosion casting and scanning electron microscopy. Computational simulations of pruning vessels suggested that serial pillars form along pre-existing velocity streamlines; blood pressure demonstrated no obvious spatial relationship with the intravascular pillars. Modeling a Re…

PeriodicityExtraembryonic MembranesNeovascularization PhysiologicChick EmbryoBiologyArticleMicrocirculationsymbols.namesakeMicroscopyShear stressAnimalsStreamlines streaklines and pathlinesComputer SimulationReynolds numberEndothelial CellsBlood flowAnatomyShear (sheet metal)Regional Blood FlowsymbolsBlood Vesselssense organsStress MechanicalCorrosion CastingDevelopmental BiologyBiomedical engineeringDevelopmental dynamics : an official publication of the American Association of Anatomists
researchProduct

Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE−/−mice and angiogenesis

2015

Background and Purpose Abdominal aortic aneurysm (AAA) is a degenerative vascular disease associated with angiogenesis. Bexarotene is a retinoid X receptor (RXR) ligand with anti-angiogenic activity. Statins also exert anti-angiogenic activity and activate PPARs. Because RXR ligands form permissive heterodimers with PPARs and a single anti-angiogenic drug may not be sufficient to combat the wide array of angiogenic factors produced during AAA, we evaluated the effect of combined low doses of bexarotene and rosuvastatin in a mouse model of AAA.

PharmacologyBexaroteneAngiogenesisPharmacologyRetinoid X receptorBiologymedicine.diseaseenvironment and public healthAngiotensin IINeovascularizationAortic aneurysmRosuvastatin Calciumcardiovascular systemmedicinelipids (amino acids peptides and proteins)Rosuvastatincardiovascular diseasesmedicine.symptommedicine.drugBritish Journal of Pharmacology
researchProduct

Statins and angiogenesis in non-cardiovascular diseases.

2022

Statins inhibit HMG-CoA reductase by competitively inhibiting the active site of the enzyme, thus preventing cholesterol synthesis and reducing the risk of developing cardiovascular disease. Many pleiotropic effects of statins have been demonstrated that can be either related or unrelated to their cholesterol-lowering ability. Among these effects are their proangiogenic and antiangiogenic properties that could offer new therapeutic applications. In this regard, pro- and anti-angiogenic properties of statins have been shown to be dose dependent. Statins also appear to have a variety of non-cardiovascular angiogenic effects in many diseases, some examples being ocular disease, brain disease, …

PharmacologyCholesterolNeovascularization PathologicCardiovascular DiseasesNeoplasmsDrug DiscoveryHumansHydroxymethylglutaryl-CoA Reductase InhibitorsAngiogenesis Bone disease Brain disease Cancer Cardiovascular Diabetes Ocular disease Preeclampsia Statins VascularizationDrug discovery today
researchProduct

Rho-mediated activation of PI(4)P5K and lipid second messengers is necessary for promotion of angiogenesis by Semaphorin 4D

2011

Phosphatidylinositol 4-phosphate 5-kinase (PI(4)P5K) is a type I lipid kinase that generates the lipid second messenger phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and functions downstream of RhoA in actin organization. It is known to play an essential role in neurite remodeling, yielding a phenotype identical to that seen in cells treated with Semaphorin 4D (Sema4D), a protein that regulates proliferation, adhesion and migration in many different cell types. Plexin-B1, the receptor for Sema4D, activates RhoA in order to generate a pro-angiogenic signal in endothelial cells. Therefore, we looked in human umbilical vein endothelial cells (HUVEC) to determine if Plexin-B1 e…

Phosphatidylinositol 45-DiphosphateCancer ResearchRHOAPhysiologyAngiogenesisSemaphorin 4DClinical BiochemistrySEMA4DNeovascularization PhysiologicNerve Tissue ProteinsReceptors Cell SurfaceSemaphorinsSynaptojaninBiologySecond Messenger SystemsArticlePI(45)P2chemistry.chemical_compoundAntigens CDRhoSettore BIO/10 - BiochimicaHumansPlexin B1PhosphatidylinositolRho-associated protein kinaseCytoskeletonrho-Associated KinasesPI(4)P5KKinaseCell biologyPhosphotransferases (Alcohol Group Acceptor)AngiogenesiHEK293 CellschemistrySecond messenger systembiology.proteinCalciumrhoA GTP-Binding ProteinAngiogenesis
researchProduct

Three-dimensional cell cultures: from molecular mechanisms to clinical applications.

1997

This article reviews actual advances in the development and application of three-dimensional (3-D) cell culture systems. Recent therapeutically oriented studies include characterization of multicellular-mediated drug resistance, novel ways of quantifying hypoxia, and new approaches to more efficient immunotherapy. Recent progress toward understanding the development of necrosis in tumor spheroids has been made using novel spheroid models. 3-D cultures have been used for studies on molecular mechanisms involved in invasion and metastasis, with a major focus on the role of E-cadherin. Similarly, tumor angiogenesis and the significance of vascular endothelial growth factor have been investigat…

PhysiologyTumor spheroidCell Culture TechniquesPhysiologyEmbryoid bodyBiologyMetastasislaw.inventionchemistry.chemical_compoundlawmedicineTumor Cells CulturedAnimalsHumansCells CulturedNeovascularization PathologicSpheroidBioartificial liver deviceCell BiologyModels Theoreticalmedicine.diseaseEmbryonic stem cellCell HypoxiaVascular endothelial growth factorchemistryCell cultureDrug Resistance NeoplasmImmunotherapyNeuroscienceThe American journal of physiology
researchProduct

Molecular insights and novel approaches for targeting tumor metastasis

2020

In recent years, due to the effective drug delivery and preciseness of tumor sites or microenvironment, the targeted drug delivery approaches have gained ample attention for tumor metastasis therapy. The conventional treatment approaches for metastasis therapy have reported with immense adverse effects because they exhibited maximum probability of killing the carcinogenic cells along with healthy cells. The tumor vasculature, comprising of vasculogenic impressions and angiogenesis, greatly depends upon the growth and metastasis in the tumors. Therefore, various nanocarriers-based delivery approaches for targeting to tumor vasculature have been attempted as efficient and potential approaches…

PolymersAngiogenesisMetal NanoparticlesPharmaceutical ScienceAntineoplastic Agents02 engineering and technologyTumor vasculature030226 pharmacology & pharmacyMetastasis03 medical and health sciencesDrug Delivery Systems0302 clinical medicineNeoplasmsTumor MicroenvironmentHumansMedicineNeoplasm MetastasisAdverse effectDrug CarriersNeovascularization Pathologicbusiness.industryConventional treatmentPhototherapy021001 nanoscience & nanotechnologymedicine.diseaseLipidsTargeted drug deliveryDrug deliveryCancer researchNanoparticlesRNANanocarriersPeptides0210 nano-technologybusinessInternational Journal of Pharmaceutics
researchProduct

Apoptosis causes lumen formation during angiogenesis in vitro.

2002

Programmed cell deathUmbilical VeinsAngiogenesisLumen (anatomy)ApoptosisBiologyBiochemistryUmbilical veinmedicineIn Situ Nick-End LabelingHumansCells CulturedNeovascularization PathologicCell BiologyIntercellular Adhesion Molecule-1ImmunohistochemistryIn vitroCell biologyEndothelial stem cellPlatelet Endothelial Cell Adhesion Molecule-1Microscopy Electronmedicine.anatomical_structureApoptosisImmunologyCollagenEndothelium VascularCardiology and Cardiovascular MedicineBlood vesselMicrovascular research
researchProduct

Role of Extracellular Vesicles in Hematological Malignancies.

2015

In recent years the role of tumor microenvironment in the progression of hematological malignancies has been widely recognized. Recent studies have focused on how cancer cells communicate within the microenvironment. Among several factors (cytokines, growth factors, and ECM molecules), a key role has been attributed to extracellular vesicles (EV), released from different cell types. EV (microvesicles and exosomes) may affect stroma remodeling, host cell functions, and tumor angiogenesis by inducing gene expression modulation in target cells, thus promoting cancer progression and metastasis. Microvesicles and exosomes can be recovered from the blood and other body fluids of cancer patients a…

ProteomicsCell typeImmunology and Microbiology (all)lcsh:MedicineReview ArticleBiologyProteomicsExosomesGeneral Biochemistry Genetics and Molecular BiologyMetastasisExtracellular VesiclesStromaSettore BIO/13 - Biologia ApplicatamedicineTumor MicroenvironmentHumansTumor microenvironmentBiochemistry Genetics and Molecular Biology (all)General Immunology and MicrobiologyNeovascularization Pathologiclcsh:RCancerGeneral Medicinemedicine.diseaseMicrovesiclesCell biologyGene Expression Regulation NeoplasticHematologic NeoplasmsCancer cellBiochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)BioMed research international
researchProduct

Proteomic Approaches in Colon Cancer: Promising Tools for New Cancer Markers and Drug Target Discovery

2005

Novel technologies are needed from which to identify new and more efficient biomarkers and improved molecular targets for the expedient and accurate diagnosis and treatment of colorectal cancer. Many advances have been made in direct and virtual imaging for detection of polyps and malignant-type lesions. These require tissue verification before definitive intervention. Inclusion of a simple serum test, more accurate than CEA, especially for early cancer detection, would make virtual imaging much more successful. Proteomics, the study of the proteins and protein pathways involved in disease, is a new dimension in preclinical and clinical development. Mass spectrometric analysis of serum prot…

ProteomicsNeovascularization PathologicColorectal cancerAngiogenesisbusiness.industryDrug targetProtein Array AnalysisGastroenterologyCancerDiseasemedicine.diseaseProteomicsBioinformaticsSensitivity and SpecificitySpecimen HandlingOncologyColonic NeoplasmsBiomarkers TumormedicineProtein microarrayHumansBiomarker (medicine)businessClinical Colorectal Cancer
researchProduct

RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization

2021

Age-related macular degeneration (AMD) is an eye disease that is characterized by damage to the central part of the retina, the macula, and that affects millions of people worldwide. At an advanced stage, a blind spot grows in the center of vision, severely handicapping patients with this degenerative condition. Despite therapeutic advances thanks to the use of anti-VEGF, many resistance mechanisms have been found to accentuate the visual deficit. In the present study, we explored whether supplementation with Resvega®, a nutraceutical formulation composed of omega-3 fatty acids and resveratrol, a well-known polyphenol in grapes, was able to counteract laser-induced choroidal neovascularizat…

Proteomicsgenetic structuresAngiogenesisAMDresveratrolPharmacologyResveratrolMacular DegenerationMiceangiogenesischemistry.chemical_compound0302 clinical medicineMedicineBiology (General)proteomicSpectroscopy0303 health sciencesomega-3 fatty acidsGeneral Medicine3. Good healthComputer Science ApplicationsChemistrymedicine.anatomical_structureChoroidal neovascularization[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansFemalemedicine.symptomQH301-705.5ArticleCatalysisInorganic Chemistry03 medical and health sciencesNutraceuticalIn vivoFatty Acids Omega-3[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyAnimals[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyIn patient[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansPhysical and Theoretical ChemistryQD1-999Molecular Biology030304 developmental biologyRetinabusiness.industryocular diseasesOrganic ChemistryMacular degenerationmedicine.diseaseChoroidal Neovascularizationeye diseasesDisease Models Animal[SDV.AEN] Life Sciences [q-bio]/Food and NutritionchemistryDietary Supplements030221 ophthalmology & optometrysense organsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionInternational Journal of Molecular Sciences
researchProduct